Susquehanna Fundamental Investments’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-50,121
Closed -$3.48M 182
2023
Q3
$3.48M Sell
50,121
-181,419
-78% -$13.7M 0.23% 111
2023
Q2
$18.7M Hold
231,540
0.69% 30
2023
Q1
$18.7M Hold
231,540
0.44% 51
2022
Q4
$17.3M Buy
231,540
+52,581
+29% +$3.74M 0.3% 94
2022
Q3
$11.5M Buy
+178,959
New +$12.4M 0.2% 142
2022
Q1
$5.24M Hold
68,146
0.1% 277
2021
Q4
$5.22M Sell
68,146
-46,114
-40% -$3.39M 0.14% 192
2021
Q3
$8.43M Buy
+114,260
New +$8.57M 0.15% 164
2021
Q2
Sell
-80,949
Closed -$6.02M 1701
2021
Q1
$6.02M Hold
80,949
0.1% 277
2020
Q4
$5.9M Buy
+80,949
New +$5.71M 0.11% 262

Other funds holding HOLX

Susquehanna Fundamental Investments's HOLX Position: Q4 2023 in Review

Susquehanna Fundamental Investments sold out of Hologic (HOLX) in Q4 2023, closing a stake of 50,121 shares — an estimated $3.48M sold.

Susquehanna Fundamental Investments first reported a position in HOLX in Q4 2020 and held it in 10 quarters. The position peaked at $18.7M in Q2 2023. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Susquehanna Fundamental Investments reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 50,121 Hologic shares in Q4 2023, an estimated $3.48M.
  • Susquehanna Fundamental Investments first reported a position in Hologic in Q4 2020 and held it in 10 quarters.
  • Susquehanna Fundamental Investments's Hologic position peaked at $18.7M in Q2 2023.
  • 733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2023, filed 14 Feb 2024.